Guilin Sanjin Pharmaceutical Co Ltd
Guilin Sanjin Pharmaceutical Co., Ltd. engages in the research, production, and sale of traditional Chinese and natural medicines in China and internationally. The company offers three gold particles, Guilin watermelon frost, watermelon frost lozenges, throat clearing spray, Naomaitai capsules, vertigo tablets, Xuanyunning granules, Gejie dingchuan capsule, compound panax notoginseng stomachache … Read more
Guilin Sanjin Pharmaceutical Co Ltd (002275) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.036x
Based on the latest financial reports, Guilin Sanjin Pharmaceutical Co Ltd (002275) has a cash flow conversion efficiency ratio of 0.036x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥117.62 Million) by net assets (CN¥3.24 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Guilin Sanjin Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2006–2024)
This chart illustrates how Guilin Sanjin Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Guilin Sanjin Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Guilin Sanjin Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Frp Holdings Ord
NASDAQ:FRPH
|
0.017x |
|
Sanyou Corporation Limited
SHE:300932
|
N/A |
|
Hangzhou Wensli Silk Culture Co. Ltd.
SHE:301066
|
N/A |
|
X Financial Class A
NYSE:XYF
|
56.676x |
|
Gaonchips Co. Ltd.
KQ:399720
|
0.103x |
|
Hua Yuan Property Co Ltd
SHG:600743
|
0.133x |
|
Lootom Telcovideo Network Wuxi Co Ltd
SHE:300555
|
-0.025x |
|
Wajax Corporation
PINK:WJXFF
|
0.026x |
Annual Cash Flow Conversion Efficiency for Guilin Sanjin Pharmaceutical Co Ltd (2006–2024)
The table below shows the annual cash flow conversion efficiency of Guilin Sanjin Pharmaceutical Co Ltd from 2006 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥3.01 Billion | CN¥588.33 Million | 0.195x | +0.25% |
| 2023-12-31 | CN¥2.82 Billion | CN¥549.25 Million | 0.195x | +3.76% |
| 2022-12-31 | CN¥2.81 Billion | CN¥528.67 Million | 0.188x | +30.08% |
| 2021-12-31 | CN¥2.84 Billion | CN¥410.24 Million | 0.144x | -28.52% |
| 2020-12-31 | CN¥2.96 Billion | CN¥597.99 Million | 0.202x | +21.50% |
| 2019-12-31 | CN¥2.82 Billion | CN¥468.29 Million | 0.166x | -15.39% |
| 2018-12-31 | CN¥2.81 Billion | CN¥551.73 Million | 0.197x | +34.52% |
| 2017-12-31 | CN¥2.65 Billion | CN¥387.82 Million | 0.146x | -33.97% |
| 2016-12-31 | CN¥2.43 Billion | CN¥536.85 Million | 0.221x | +30.14% |
| 2015-12-31 | CN¥2.34 Billion | CN¥398.50 Million | 0.170x | -0.47% |
| 2014-12-31 | CN¥2.32 Billion | CN¥396.53 Million | 0.171x | +19.83% |
| 2013-12-31 | CN¥2.20 Billion | CN¥314.16 Million | 0.143x | -2.08% |
| 2012-12-31 | CN¥2.08 Billion | CN¥302.59 Million | 0.146x | -15.34% |
| 2011-12-31 | CN¥1.98 Billion | CN¥341.05 Million | 0.172x | +8.44% |
| 2010-12-31 | CN¥1.80 Billion | CN¥285.49 Million | 0.159x | -22.16% |
| 2009-12-31 | CN¥1.78 Billion | CN¥363.29 Million | 0.204x | -16.01% |
| 2008-12-31 | CN¥787.10 Million | CN¥190.97 Million | 0.243x | +7.63% |
| 2007-12-31 | CN¥729.25 Million | CN¥164.39 Million | 0.225x | -35.03% |
| 2006-12-31 | CN¥627.33 Million | CN¥217.67 Million | 0.347x | -- |